 Heres a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Verve Therapeutics, Vertex Join Forces For Liver Disease-Focused Gene Program Vertex Pharmaceuticals Incorporated NASDAQ: VRTX and Verve Therapeutics Inc NASDAQ: VERV announced. 